Discounted Cash Flow Rating
Strong Sell
Return on Equity Rating
Strong Buy
Debt to Equity Rating
Strong Sell
Price to Earnings Rating
Strong Sell
Analyst Rating
Sell
Simple Moving Average
Neutral
Exponential Moving Average
Neutral
Relative Strength Index
Strong Buy
Standard Deviation
Strong Sell
Williams %R
Strong Buy
Average Directional Index
Strong Sell
Insider Trading
Neutral
Wall Street Data Solutions Rating
Neutral
B
SeaStar Medical Holding Corporation Warrant (ICUCW)
Surgical & Medical Instruments & Apparatus
https://www.seastarmedical.com
SeaStar Medical Holding Corp is a medical technology company developing proprietary solutions to reduce the consequences of hyperinflammation on vital organs. It is developing and commercializing extracorporeal therapies that target the effector cells that drive systemic inflammation, causing direct tissue damage and secreting a range of pro-inflammatory cytokines that initiate and propagate imbalanced immune responses.
3513 BRIGHTON BLVD, SUITE 410
DENVER, CO
Current Price
---.--
% Change Today
0.00%
Change Amt. Today
0.00
Active Status
Active
Listing Date
10/31/2022
Market Cap
22,870,723
Shares Outstanding
27,200,000
Weighted SO
N/A
Total Employees
N/A
Upcoming Earnings
N/A
Similar Tickers
Beta
-1.0430
Last Div
0.0000
Range
0.04-0.0696
Chg
-0.0049
Avg Vol
N/A
Mkt Cap
22870723
Exch
NASDAQ
Country
US
Phone
844-427-8100
DCF Diff
23.2733
DCF
-10.2733
Div Yield
0.0000
P/S
0.0000
EV Multiple
-2.0383
P/FV
-2992.0371
Div Yield %
0.0000
P/E
-621.2929
PEG
-10.9330
Payout
0.0000
Current Ratio
0.2431
Quick Ratio
0.2431
Cash Ratio
0.1187
DSO
0.0000
DIO
0.0000
Op Cycle
0.0000
DPO
0.0000
CCC
0.0000
Gross Margin
0.0000
Op Margin
0.0000
Pretax Margin
0.0000
Net Margin
0.0000
Eff Tax Rate
-0.0054
ROA
-9.5858
ROE
3.2308
ROCE
2.2432
NI/EBT
0.9999
EBT/EBIT
2.2925
EBIT/Rev
0.0000
Debt Ratio
0.9057
D/E
-0.4550
LT Debt/Cap
0.0000
Total Debt/Cap
-0.8349
Int Coverage
-29.9545
CF/Debt
-2.9650
Equity Multi
-0.5024
Rec Turnover
0.0000
Pay Turnover
0.0000
Inv Turnover
0.0000
FA Turnover
0.0000
Asset Turnover
0.0000
OCF/Share
-0.0030
FCF/Share
-0.0030
Cash/Share
0.0004
OCF/Sales
0.0000
FCF/OCF
1.0000
CF Coverage
-2.9650
ST Coverage
-2.9650
CapEx Coverage
0.0000
Div&CapEx Cov
0.0000
P/BV
-2992.0371
P/B
-2992.0371
P/S
0.0000
P/E
-621.2929
P/FCF
-2.9308
P/OCF
-2217.8355
P/CF
-2217.8355
PEG
-10.9330
P/S
0.0000
EV Multiple
-2.0383
P/FV
-2992.0371
DPS
0.0000
Latest Headlines (EST)
Revenue Product Segmentation
Year | Purchases | Sales | Total Bought | Total Sold |
---|
Transaction Date | Name | Type Of Owner | Price | Securities Owned | Securities Transacted | Security Name | Transaction Type |
---|
Less Than 3 Months
0.00 Shares Bought (0 %)
0.00 Shares Sold (0%)
3 - 6 Months
0.00 Shares Bought (0 %)
0.00 Shares Sold (0%)
6 - 9 Months
0.00 Shares Bought (0 %)
0.00 Shares Sold (0%)
9 - 12 Months
0.00 Shares Bought (0 %)
0.00 Shares Sold (0 %)
Investor Name | Investment Discretion | Type of Security | Shares Owned | Avg Price Paid | Market Value | Change In Market Value | Change In Market Value (%) | Ownership | Weight |
---|
Date | Investors Holding | Closed Positions | Increased Positions | Reduced Positions | New Positions | Total Invested | Put/Call Ratio | Total Calls | Total Puts |
---|
Owner | Shares Owned |
---|
2021 | 2023 | 2024 | 2024 | 1970 | 1970 | 1970 | |
---|---|---|---|---|---|---|---|
Revenue | 0.00 | 0.00 | 0.00 | 0.00 | |||
Cost Of Revenue | 0.00 | 0.00 | 0.00 | 0.00 | |||
Gross Profit | 0.00 | 0.00 | 0.00 | 0.00 | |||
Gross Profit Ratio | 0.00 | 0.00 | 0.00 | 0.00 | ▼ | ||
Research And Development Expenses | 536.00K | ▲ 1.14M | ▼ 1.08M | ▲ 1.70M | ▼ | ||
General And Administrative Expenses | 652.00K | ▲ 4.39M | ▼ 1.87M | ▲ 2.25M | ▼ | ||
Selling And Marketing Expenses | 0.00 | 0.00 | 0.00 | 0.00 | |||
Selling General And Administrative Expenses | 652.00K | ▲ 4.39M | ▼ 1.87M | ▲ 2.25M | ▼ | ||
Other Expenses | 91.00K | ▼ 0.00 | ▼ -5.09M | ▲ 0.00 | |||
Operating Expenses | 1.19M | ▲ 7.72M | ▼ 2.94M | ▲ 3.95M | ▼ | ||
Cost And Expenses | 1.19M | ▲ 7.72M | ▼ 2.94M | ▲ 3.95M | ▼ | ||
Interest Income | 0.00 | ▲ 147.00 | ▼ 0.00 | 0.00 | |||
Interest Expense | 9.00K | ▲ 147.00K | ▲ 199.00K | ▼ -143.00K | ▼ | ||
Depreciation And Amortization | 91.00K | ▼ -1.00K | ▲ 2.94K | ▲ 3.95M | ▼ | ||
Ebitda | -1.10M | ▼ -7.72M | ▲ -2.94M | ▼ -3.95M | ▼ | ||
Ebitda Ratio | 0.00 | 0.00 | 0.00 | 0.00 | ▼ | ||
Operating Income | -1.19M | ▼ -7.72M | ▲ -2.94M | ▼ -3.95M | ▼ | ||
Operating Income Ratio | 0.00 | 0.00 | 0.00 | 0.00 | ▼ | ||
Total Other Income Expenses Net | 91.00K | ▼ -11.35M | ▲ -6.94M | ▼ -8.75M | ▼ | ||
Income Before Tax | -1.11M | ▼ -19.22M | ▲ -9.88M | ▼ -12.70M | ▼ | ||
Income Before Tax Ratio | 0.00 | 0.00 | 0.00 | 0.00 | ▼ | ||
Income Tax Expense | 9.00K | ▲ 147.00K | ▼ -5.00K | ▼ -3.95M | ▼ | ||
Net Income | -1.11M | ▼ -19.22M | ▲ -9.88M | ▼ -12.70M | ▼ | ||
Net Income Ratio | 0.00 | 0.00 | 0.00 | 0.00 | ▼ | ||
Eps | -0.15 | ▼ -1.51 | ▲ -0.26 | ▲ -0.19 | ▼ | ||
Eps Diluted | -0.15 | ▼ -1.51 | ▲ -0.26 | ▲ -0.19 | ▼ | ||
Weighted Average Shs Out | 7.24M | ▲ 12.70M | ▲ 38.60M | ▲ 67.11M | ▼ | ||
Weighted Average Shs Out Dil | 7.24M | ▲ 12.70M | ▲ 38.60M | ▲ 67.11M | ▼ |